Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Global Market Study on Veterinary Molecular Diagnostics: Increasing Prevalence of Zoonotic Diseases among Livestock & Companion Animals to Spur Growth

Published by Persistence Market Research Product code 977665
Published Content info 269 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global Market Study on Veterinary Molecular Diagnostics: Increasing Prevalence of Zoonotic Diseases among Livestock & Companion Animals to Spur Growth
Published: November 17, 2020 Content info: 269 Pages
Description

Scope of the Report:

A latest publication by Persistence Market Research (PMR) on the global veterinary molecular diagnostics market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the global veterinary molecular diagnostics market. The study offers detailed insights on key market dynamics, which includes the drivers, restraints, trends, and opportunities in the veterinary molecular diagnostics market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2020-2030.

Important indicators for the successful growth of the veterinary molecular diagnostics market are presented in this comprehensive report, which include supply chain analysis, value chain analysis, Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR. This research study can support readers to know the demand for veterinary molecular diagnostic products and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the veterinary molecular diagnostics market, including market investors and service providers, and can help them in developing suitable business strategies to flourish in the veterinary molecular diagnostics market. The insights and wisdom presented in this PMR study can be leveraged by shareholders in the veterinary molecular diagnostics market, industry experts, investors, researchers, reporters, as well as business enthusiasts.

Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the veterinary molecular diagnostics market are also included in the current study. Depending on potential developments in the veterinary molecular diagnostics market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this report, minor companies and new entrants in the veterinary molecular diagnostics industry can be aided in making suitable company choices to achieve traction in the market space.

Key Segmentation:

PMR's study on the veterinary molecular diagnostics market offers information divided into five important segments-product, disease, species, end user, and region. This report offers comprehensive data and information about the important market dynamics, and growth parameters associated with these categories.

Product

  • PCR Kits
  • RT-PCR Kits
  • RAPD-PCR Kits
  • INAAT Kits
  • Microarray Kits
  • DNA Sequencing Kits

Disease

  • Anaplasma spp.
  • Ehrlichia spp.
  • New Castle Disease
  • Influenza
  • Porcine Reproductive & Respiratory Syndrome (PRRS)
  • Others

Species

  • Livestock Animals
    • Equine
    • Porcine
    • Poultry
    • Bovine/Cattle
    • Aquatic
    • Ovine
  • Companion Animals
    • Canine
    • Feline
    • Avian

End User

  • Veterinary Hospitals
  • Clinical Laboratories
  • Veterinary Research Institutes

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Key Questions Answered:

  • Which regions will continue to remain the most profitable regional markets for veterinary molecular diagnostics?
  • Which factors will induce a change in the demand for veterinary molecular diagnostics during the assessment period?
  • How will COVID-19 change the trends in the veterinary molecular diagnostics market?
  • How can market players capture the low-hanging opportunities in the veterinary molecular diagnostics market in developed regions?
  • What are the winning strategies of stakeholders in the veterinary molecular diagnostics market to upscale their position in this landscape?
  • What are the restraints that investors need to be aware of and tackle while investing in the veterinary molecular diagnostics market?
  • What are the developmental trends in veterinary molecular diagnostics sectors that will impact the market?
  • How can businesses in the veterinary molecular diagnostics market avail the growth opportunities in developed and emerging economies?

Research Methodology:

In PMR's study, a unique research methodology is utilized to conduct extensive research on the growth of the veterinary molecular diagnostics market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the veterinary molecular diagnostics market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts interviewed specialized industry experts, medical professionals using veterinary molecular diagnostics, and key executive of product manufacturing companies, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the veterinary molecular diagnostics market, and makes PMR's projections on the growth prospects of the veterinary molecular diagnostics market more accurate and reliable.

Table of Contents
Product Code: PMRREP12874

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusion and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Market Context

  • 4.1. Product Penetration
  • 4.2. Key Regulations
  • 4.3. Key Competition Mapping

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Increasing Urbanization and Growing Affluence in Emerging Countries
    • 5.1.2. Growing Demand for Precise Molecular Diagnosis Coupled with Increasing Obesity Rate
    • 5.1.3. Increasing Awareness Towards Pet Health
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Rise in Awareness About Diseases in Animals Worldwide
    • 5.2.2. High Adoption of Molecular Diagnostic Kits for Veterinary Applications
    • 5.2.3. Higher Prevalence of Chronic & Infectious Diseases in Animals
    • 5.2.4. Increasing Strategic Collaborations Among Key Players
    • 5.2.5. Advancements in Molecular Technology
    • 5.2.6. Growing Acceptance of Advanced Molecular Diagnostic Techniques
    • 5.2.7. Ease In FDA Clearance
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis
  • 5.4. COVID19 Crisis Analysis
    • 5.4.1. Current COVID19 Statistics and Probable Future Impact
    • 5.4.2. Current GDP Projection and Probable Impact
    • 5.4.3. Current Economic Projection as compared to 2008 Economic analysis
    • 5.4.4. COVID19 and Impact Analysis
      • 5.4.4.1. Revenue By Product Type
      • 5.4.4.2. Revenue By Disease Type
      • 5.4.4.3. Revenue By Species Type
      • 5.4.4.4. Revenue By End User
      • 5.4.4.5. Revenue By Country
    • 5.4.5. 2020 Market Scenario
    • 5.4.6. Quarter by Quarter Forecast
    • 5.4.7. Projected recovery Quarter
    • 5.4.8. Recovery Scenario - Short term, Midterm and Long Term Impact

6. Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

  • 6.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
  • 6.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
    • 6.2.1. Y-o-Y Growth Trend Analysis
    • 6.2.2. Absolute $ Opportunity Analysis

7. Global Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, by Product Type

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size (US$ Mn) By Product Type, 2015-2019
  • 7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2020-2030
    • 7.3.1. PCR Kits
      • 7.3.1.1. RT-PCR Kits
      • 7.3.1.2. RAPD-PCR Kits
    • 7.3.2. INAAT Kits
    • 7.3.3. Microarray Kits
    • 7.3.4. DNA Sequencing Kits
  • 7.4. Market Attractiveness Analysis By Product Type

8. Global Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, by Disease Type

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) By Disease Type, 2015-2019
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease Type, 2020-2030
    • 8.3.1. Anaplasma spp.
    • 8.3.2. Ehrlichia spp.
    • 8.3.3. New Castle Disease
    • 8.3.4. Influenza
    • 8.3.5. Porcine Reproductive & Respiratory Syndrome (PRRS)
    • 8.3.6. Others
  • 8.4. Market Attractiveness Analysis By Disease Type

9. Global Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, by Species Type

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By Species Type, 2015-2019
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Species Type, 2020-2030
    • 9.3.1. Livestock Animals
      • 9.3.1.1. Equine
      • 9.3.1.2. Porcine
      • 9.3.1.3. Poultry
      • 9.3.1.4. Bovine/Cattle
      • 9.3.1.5. Aquatic
      • 9.3.1.6. Ovine
    • 9.3.2. Companion Animals
      • 9.3.2.1. Canine
      • 9.3.2.2. Feline
      • 9.3.2.3. Avian
  • 9.4. Market Attractiveness Analysis By Species Type

10. Global Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, by End User

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By End User, 2015-2019
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2020-2030
    • 10.3.1. Veterinary Hospitals
    • 10.3.2. Clinical Laboratories
    • 10.3.3. Veterinary Research Institutes
  • 10.4. Market Attractiveness Analysis By End User

11. Global Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, by Region

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Analysis By Region, 2014 - 2018
  • 11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 - 2029
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. East Asia
    • 11.3.5. South Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East and Africa (MEA)
  • 11.4. Market Attractiveness Analysis By Region

12. North America Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
  • 12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Product Type
    • 12.3.3. By Disease Type
    • 12.3.4. By Species Type
    • 12.3.5. By End User
  • 12.4. Market Attractiveness Analysis
  • 12.5. Key Market Participants - Intensity Mapping
  • 12.6. Drivers and Restraints - Impact Analysis

13. Latin America Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2018
  • 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
    • 13.3.1. By Country
      • 13.3.1.1. Brazil
      • 13.3.1.2. Mexico
      • 13.3.1.3. Argentina
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Product Type
    • 13.3.3. By Disease Type
    • 13.3.4. By Species Type
    • 13.3.5. By End User
  • 13.4. Market Attractiveness Analysis
  • 13.5. Key Market Participants - Intensity Mapping
  • 13.6. Drivers and Restraints - Impact Analysis

14. Europe Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
  • 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy2020-2030
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. Italy
      • 14.3.1.3. France
      • 14.3.1.4. U.K.
      • 14.3.1.5. Spain
      • 14.3.1.6. BENELUX
      • 14.3.1.7. Russia
      • 14.3.1.8. Rest of Europe
    • 14.3.2. By Product Type
    • 14.3.3. By Disease Type
    • 14.3.4. By Species Type
    • 14.3.5. By End User
  • 14.4. Market Attractiveness Analysis
  • 14.5. Key Market Participants - Intensity Mapping
  • 14.6. Drivers and Restraints - Impact Analysis

15. South Asia Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
  • 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy2020-2030
    • 15.3.1. By Country
      • 15.3.1.1. India
      • 15.3.1.2. Thailand
      • 15.3.1.3. Indonesia
      • 15.3.1.4. Malaysia
      • 15.3.1.5. Rest of South Asia
    • 15.3.2. By Product Type
    • 15.3.3. By Disease Type
    • 15.3.4. By Species Type
    • 15.3.5. By End User
  • 15.4. Market Attractiveness Analysis
  • 15.5. Key Market Participants - Intensity Mapping
  • 15.6. Drivers and Restraints - Impact Analysis

16. East Asia Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
  • 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
    • 16.3.1. By Country
      • 16.3.1.1. China
      • 16.3.1.2. Japan
      • 16.3.1.3. South Korea
    • 16.3.2. By Product Type
    • 16.3.3. By Disease Type
    • 16.3.4. By Species Type
    • 16.3.5. By End User
  • 16.4. Market Attractiveness Analysis
  • 16.5. Key Market Participants - Intensity Mapping
  • 16.6. Drivers and Restraints - Impact Analysis

17. Oceania Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
  • 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. By Product Type
    • 17.3.3. By Disease Type
    • 17.3.4. By Species Type
    • 17.3.5. By End User
  • 17.4. Market Attractiveness Analysis
  • 17.5. Key Market Participants - Intensity Mapping
  • 17.6. Drivers and Restraints - Impact Analysis

18. Middle East and Africa Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
  • 18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Turkey
      • 18.3.1.3. South Africa
      • 18.3.1.4. Rest of Middle East and Africa
    • 18.3.2. By Product Type
    • 18.3.3. By Disease Type
    • 18.3.4. By Species Type
    • 18.3.5. By End User
  • 18.4. Market Attractiveness Analysis
  • 18.5. Key Market Participants - Intensity Mapping
  • 18.6. Drivers and Restraints - Impact Analysis

19. Key and Emerging Countries Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

  • 19.1. Introduction
    • 19.1.1. Market Value Proportion Analysis, By Key Countries
    • 19.1.2. Global Vs. Country Growth Comparison
  • 19.2. U.S. Veterinary Molecular Diagnostics Market Analysis
    • 19.2.1. By Product Type
    • 19.2.2. By Disease Type
    • 19.2.3. By Species Type
    • 19.2.4. By End User
  • 19.3. Canada Veterinary Molecular Diagnostics Market Analysis
    • 19.3.1. By Product Type
    • 19.3.2. By Disease Type
    • 19.3.3. By Species Type
    • 19.3.4. By End User
  • 19.4. Mexico Veterinary Molecular Diagnostics Market Analysis
    • 19.4.1. By Product Type
    • 19.4.2. By Disease Type
    • 19.4.3. By Species Type
    • 19.4.4. By End User
  • 19.5. Brazil Veterinary Molecular Diagnostics Market Analysis
    • 19.5.1. By Product Type
    • 19.5.2. By Disease Type
    • 19.5.3. By Species Type
    • 19.5.4. By End User
  • 19.6. U.K. Veterinary Molecular Diagnostics Market Analysis
    • 19.6.1. By Product Type
    • 19.6.2. By Disease Type
    • 19.6.3. By Species Type
    • 19.6.4. By End User
  • 19.7. Germany Veterinary Molecular Diagnostics Market Analysis
    • 19.7.1. By Product Type
    • 19.7.2. By Disease Type
    • 19.7.3. By Species Type
    • 19.7.4. By End User
  • 19.8. France Veterinary Molecular Diagnostics Market Analysis
    • 19.8.1. By Product Type
    • 19.8.2. By Disease Type
    • 19.8.3. By Species Type
    • 19.8.4. By End User
  • 19.9. Italy Veterinary Molecular Diagnostics Market Analysis
    • 19.9.1. By Product Type
    • 19.9.2. By Disease Type
    • 19.9.3. By Species Type
    • 19.9.4. By End User
  • 19.10. Spain Veterinary Molecular Diagnostics Market Analysis
    • 19.10.1. By Product Type
    • 19.10.2. By Disease Type
    • 19.10.3. By Species Type
    • 19.10.4. By End User
  • 19.11. BENELUX Veterinary Molecular Diagnostics Market Analysis
    • 19.11.1. By Product Type
    • 19.11.2. By Disease Type
    • 19.11.3. By Species Type
    • 19.11.4. By End User
  • 19.12. Russia Veterinary Molecular Diagnostics Market Analysis
    • 19.12.1. By Product Type
    • 19.12.2. By Disease Type
    • 19.12.3. By Species Type
    • 19.12.4. By End User
  • 19.13. China Veterinary Molecular Diagnostics Market Analysis
    • 19.13.1. By Product Type
    • 19.13.2. By Disease Type
    • 19.13.3. By Species Type
    • 19.13.4. By End User
  • 19.14. Japan Veterinary Molecular Diagnostics Market Analysis
    • 19.14.1. By Product Type
    • 19.14.2. By Disease Type
    • 19.14.3. By Species Type
    • 19.14.4. By End User
  • 19.15. South Korea Veterinary Molecular Diagnostics Market Analysis
    • 19.15.1. By Product Type
    • 19.15.2. By Disease Type
    • 19.15.3. By Species Type
    • 19.15.4. By End User
  • 19.16. India Veterinary Molecular Diagnostics Market Analysis
    • 19.16.1. By Product Type
    • 19.16.2. By Disease Type
    • 19.16.3. By Species Type
    • 19.16.4. By End User
  • 19.17. ASEAN Veterinary Molecular Diagnostics Market Analysis
    • 19.17.1. By Product Type
    • 19.17.2. By Disease Type
    • 19.17.3. By Species Type
    • 19.17.4. By End User
  • 19.18. Australia Veterinary Molecular Diagnostics Market Analysis
    • 19.18.1. By Product Type
    • 19.18.2. By Disease Type
    • 19.18.3. By Species Type
    • 19.18.4. By End User
  • 19.19. New Zealand Veterinary Molecular Diagnostics Market Analysis
    • 19.19.1. By Product Type
    • 19.19.2. By Disease Type
    • 19.19.3. By Species Type
    • 19.19.4. By End User
  • 19.20. GCC Countries Veterinary Molecular Diagnostics Market Analysis
    • 19.20.1. By Product Type
    • 19.20.2. By Disease Type
    • 19.20.3. By Species Type
    • 19.20.4. By End User
  • 19.21. Turkey Veterinary Molecular Diagnostics Market Analysis
    • 19.21.1. By Product Type
    • 19.21.2. By Disease Type
    • 19.21.3. By Species Type
    • 19.21.4. By End User
  • 19.22. South Africa Veterinary Molecular Diagnostics Market Analysis
    • 19.22.1. By Product Type
    • 19.22.2. By Disease Type
    • 19.22.3. By Species Type
    • 19.22.4. By End User

20. Competition Analysis

  • 20.1. Competition Dashboard
  • 20.2. Competition Benchmarking
  • 20.3. Competition Deep Dive
      • 20.3.1.1. bioMerieux SA
      • 20.3.1.2. Overview
      • 20.3.1.3. Product Portfolio
      • 20.3.1.4. Profitability by Market Segments (Product/Channel/Region)
      • 20.3.1.5. Sales Footprint
      • 20.3.1.6. Strategy Overview
        • 20.3.1.6.1. Marketing Strategy
        • 20.3.1.6.2. Product Strategy
        • 20.3.1.6.3. Channel Strategy
    • 20.3.2. IDEXX Laboratories, Inc.
      • 20.3.2.1. Overview
      • 20.3.2.2. Product Portfolio
      • 20.3.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 20.3.2.4. Sales Footprint
      • 20.3.2.5. Strategy Overview
        • 20.3.2.5.1. Marketing Strategy
        • 20.3.2.5.2. Product Strategy
        • 20.3.2.5.3. Channel Strategy
    • 20.3.3. Thermo Fisher Scientific Inc.
      • 20.3.3.1. Overview
      • 20.3.3.2. Product Portfolio
      • 20.3.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 20.3.3.4. Sales Footprint
      • 20.3.3.5. Strategy Overview
        • 20.3.3.5.1. Marketing Strategy
        • 20.3.3.5.2. Product Strategy
        • 20.3.3.5.3. Channel Strategy
    • 20.3.4. Qiagen N.V.
      • 20.3.4.1. Overview
      • 20.3.4.2. Product Portfolio
      • 20.3.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 20.3.4.4. Sales Footprint
      • 20.3.4.5. Strategy Overview
        • 20.3.4.5.1. Marketing Strategy
        • 20.3.4.5.2. Product Strategy
        • 20.3.4.5.3. Channel Strategy
    • 20.3.5. Neogen Corporation
      • 20.3.5.1. Overview
      • 20.3.5.2. Product Portfolio
      • 20.3.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 20.3.5.4. Sales Footprint
      • 20.3.5.5. Strategy Overview
        • 20.3.5.5.1. Marketing Strategy
        • 20.3.5.5.2. Product Strategy
        • 20.3.5.5.3. Channel Strategy
    • 20.3.6. ID.Vet
      • 20.3.6.1. Overview
      • 20.3.6.2. Product Portfolio
      • 20.3.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 20.3.6.4. Sales Footprint
      • 20.3.6.5. Strategy Overview
        • 20.3.6.5.1. Marketing Strategy
        • 20.3.6.5.2. Product Strategy
        • 20.3.6.5.3. Channel Strategy
    • 20.3.7. INDICAL BIOSCIENCE GmbH
      • 20.3.7.1. Overview
      • 20.3.7.2. Product Portfolio
      • 20.3.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 20.3.7.4. Sales Footprint
      • 20.3.7.5. Strategy Overview
        • 20.3.7.5.1. Marketing Strategy
        • 20.3.7.5.2. Product Strategy
        • 20.3.7.5.3. Channel Strategy
    • 20.3.8. Veterinary Molecular Diagnostics, Inc.
      • 20.3.8.1. Overview
      • 20.3.8.2. Product Portfolio
      • 20.3.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 20.3.8.4. Sales Footprint
      • 20.3.8.5. Strategy Overview
        • 20.3.8.5.1. Marketing Strategy
        • 20.3.8.5.2. Product Strategy
        • 20.3.8.5.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology

List of Tables

  • Table 01: Global Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 02: Global Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Disease Type
  • Table 03: Global Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Species
  • Table 04: Global Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2017 and Forecast 2020-2030, By End User
  • Table 05: Global Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2017 and Forecast 2020-2030, By Region
  • Table 06: North America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 07: North America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 08: North America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Disease Type
  • Table 09: North America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Species
  • Table 10: North America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 11: Latin America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 12: Latin America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 13: Latin America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Disease Type
  • Table 14: Latin America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Species type
  • Table 15: Latin America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 16: Europe Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 17: Europe Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 18: Europe Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Disease Type
  • Table 19: Europe Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Species Type
  • Table 20: Europe Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 21: South Asia Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 22: South Asia Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 23: South Asia Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Disease Type
  • Table 24: South Asia Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Species Type
  • Table 25: South Asia Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 26: East Asia Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 27: East Asia Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 28: East Asia Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Disease Type
  • Table 29: East Asia Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Species Type
  • Table 30: East Asia Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 31: Oceania Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 32: Oceania Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 33: Oceania Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Disease Type
  • Table 34: Oceania Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Species Type
  • Table 35: Oceania Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 36: MEA Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 37: MEA Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 38: MEA Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Disease Type
  • Table 39: MEA Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Species Type
  • Table 40: MEA Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User

List of Figures

  • Figure 01: Global Veterinary Molecular Diagnostics Market Value Analysis and Forecast, 2020-2030 (US$ Mn)
  • Figure 02: Global Veterinary Molecular Diagnostics Market Absolute $ Opportunity (US$ Mn), 2020-2030
  • Figure 03: Global Veterinary Molecular Diagnostics Market Share Analysis (%) By Product Type, 2020 & 2030
  • Figure 04: Global Veterinary Molecular Diagnostics Market Y-o-Y Growth (%) By Product Type, 2020-2030
  • Figure 05: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis By Product Type, 2020-2030
  • Figure 06: Global Veterinary Molecular Diagnostics Market Share Analysis (%) By Disease Type, 2020 & 2030
  • Figure 07: Global Veterinary Molecular Diagnostics Market Y-o-Y Growth (%) By Disease Type, 2020-2030
  • Figure 08: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis By Disease Type, 2020-2030
  • Figure 09: Global Veterinary Molecular Diagnostics Market Share Analysis (%) By Species, 2020 & 2030
  • Figure 10: Global Veterinary Molecular Diagnostics Market Y-o-Y Growth (%) By Species, 2020-2030
  • Figure 11: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis By Species, 2020-2030
  • Figure 12: Global Veterinary Molecular Diagnostics Market Share Analysis (%) By End User, 2020 & 2030
  • Figure 13: Global Veterinary Molecular Diagnostics Market Y-o-Y Growth (%) By End User, 2020-2030
  • Figure 14: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis By End User, 2020-2030
  • Figure 15: Global Veterinary Molecular Diagnostics Market Share Analysis (%) By Region, 2020 & 2030
  • Figure 16: Global Veterinary Molecular Diagnostics Market Y-o-Y Growth (%) By Region, 2020-2030
  • Figure 17: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis By Region, 2020-2030
  • Figure 18: North America Veterinary Molecular Diagnostics Market Value Share, By Product Type
  • Figure 19: North America Veterinary Molecular Diagnostics Market Value Share, By Disease Type
  • Figure 20: North America Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 21: North America Veterinary Molecular Diagnostics Market Value Share (2020E), By Country
  • Figure 22: North America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, 2015-2019
  • Figure 23: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2020-2030
  • Figure 24: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Product Type
  • Figure 25: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type
  • Figure 26: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Species
  • Figure 27: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By End User
  • Figure 28: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Country
  • Figure 29: Latin America Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 30: Latin America Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 31: Latin America Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 32: Latin America Veterinary Molecular Diagnostics Market Value Share (2020E), By Country
  • Figure 33: Latin America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, 2015-2019
  • Figure 34: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2020-2030
  • Figure 35: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Product Type
  • Figure 36: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type
  • Figure 37: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Species
  • Figure 38: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By End User
  • Figure 39: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Country
  • Figure 40: Europe Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 41: Europe Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 42: Europe Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 43: Europe America Veterinary Molecular Diagnostics Market Value Share (2020E), By Country
  • Figure 44: Europe Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, 2015-2019
  • Figure 45: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2020-2030
  • Figure 46: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Product Type
  • Figure 47: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type
  • Figure 48: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Species
  • Figure 49: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, By End User
  • Figure 50: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Country
  • Figure 51: South Asia Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 52: South Asia Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 53: South Asia Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 54: South Asia America Veterinary Molecular Diagnostics Market Value Share (2020E), By Country
  • Figure 55: South Asia Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, 2015-2019
  • Figure 56: South Asia Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2020-2030
  • Figure 57: South Asia Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Product Type
  • Figure 58: South Asia Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type
  • Figure 59: South Asia Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Species
  • Figure 60: South Asia Veterinary Molecular Diagnostics Market Attractiveness Analysis, By End User
  • Figure 61: South Asia Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Country
  • Figure 62: East Asia Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 63: East Asia Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 64: East Asia Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 65: East Asia Veterinary Molecular Diagnostics Market Value Share (2020E), By Country
  • Figure 66: East Asia Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, 2015-2019
  • Figure 67: East Asia Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2020-2030
  • Figure 68: East Asia Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Product Type
  • Figure 69: East Asia Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type
  • Figure 70: East Asia Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Species
  • Figure 71: East Asia Veterinary Molecular Diagnostics Market Attractiveness Analysis, By End User
  • Figure 72: East Asia Asia Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Country
  • Figure 73: Oceania Veterinary Molecular Diagnostics Market Value Share, By Product Type (2019A)
  • Figure 74: Oceania Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2019A)
  • Figure 75: Oceania Veterinary Molecular Diagnostics Market Value Share (2019A), By Species & End User
  • Figure 76: Oceania Veterinary Molecular Diagnostics Market Value Share (2019A), By Country
  • Figure 77: Oceania Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, 2015-2019
  • Figure 78: Oceania Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2020-2030
  • Figure 79: Oceania Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Product Type
  • Figure 80: Oceania Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type
  • Figure 81: Oceania Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Species
  • Figure 82: Oceania Veterinary Molecular Diagnostics Market Attractiveness Analysis, By End User
  • Figure 83: Oceania Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Country
  • Figure 84: MEA Veterinary Molecular Diagnostics Market Value Share, By Product Type (2019A)
  • Figure 85: MEA Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2019A)
  • Figure 86: MEA Veterinary Molecular Diagnostics Market Value Share (2019A), By Species & End User
  • Figure 87: MEA Veterinary Molecular Diagnostics Market Value Share (2019A), By Country
  • Figure 88: MEA Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, 2015-2019
  • Figure 89: MEA Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2020-2030
  • Figure 90: MEA Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Product Type
  • Figure 91: MEA Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type
  • Figure 92: MEA Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Species
  • Figure 93: MEA Veterinary Molecular Diagnostics Market Attractiveness Analysis, By End User
  • Figure 94 MEA Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Country
  • Figure 95: U.S. Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 96: U.S. Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 97: U.S. Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 98: Canada Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 99: Canada Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 100: Canada Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 101: Brazil Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 102: Brazil Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 103: Brazil Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 104: Mexico Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 105: Mexico Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 105: Mexico Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 107: U.K. Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 108: U.K. Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 109: U.K. Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 110: Germany Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 111: Germany Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 112: Germany Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 113: France Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 114: France Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 115: France Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 116: Italy Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 117: Italy Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 118: Italy Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 119: Spain Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 120: Spain Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 121: Spain Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 122: Russia Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 123: Russia Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 124: Russia Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 125: India Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 126: India Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 127: India Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 128: Thailand Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 129: Thailand Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 130: Thailand Veterinary Molecular Diagnostics Market Value Share (2020E) By Species & End User
  • Figure 131: Indonesia Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 132: Indonesia Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 133: Indonesia Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 134: Malaysia Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 135: Malaysia Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 136: Malaysia Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 137: China Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 138: China Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 139: China Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 140: Japan Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 141: Japan Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 142: Japan Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 143: South Korea Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 144: South Korea Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E))
  • Figure 145: South Korea Veterinary Molecular Diagnostics Market Value Share (2020E)), By Species & End User
  • Figure 146: Australia Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 147: Australia Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 148: Australia Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 149: New Zealand Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 150: New Zealand Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 151: New Zealand Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 152: GCC Countries Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 153: GCC Countries Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 154: GCC Countries Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 155: South Africa Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 156: South Africa Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 157: South Africa Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
Back to Top